Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study.

Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE.

Neuropsychopharmacology. 2012 Aug;37(9):2143-52. doi: 10.1038/npp.2012.66. Epub 2012 May 2.

2.

Glutamate: the new frontier in pharmacotherapy for cocaine addiction.

Uys JD, LaLumiere RT.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):482-91. Review.

PMID:
19128205
3.

N-acetylcysteine for treating cocaine addiction - A systematic review.

Nocito Echevarria MA, Andrade Reis T, Ruffo Capatti G, Siciliano Soares V, da Silveira DX, Fidalgo TM.

Psychiatry Res. 2017 May;251:197-203. doi: 10.1016/j.psychres.2017.02.024. Epub 2017 Feb 11. Review.

PMID:
28213190
4.

Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Haile CN, Mahoney JJ 3rd, Newton TF, De La Garza R 2nd.

Pharmacol Ther. 2012 May;134(2):260-77. doi: 10.1016/j.pharmthera.2012.01.010. Epub 2012 Jan 31. Review.

5.

Agonist Medications for the Treatment of Cocaine Use Disorder.

Negus SS, Henningfield J.

Neuropsychopharmacology. 2015 Jul;40(8):1815-25. doi: 10.1038/npp.2014.322. Epub 2014 Dec 11. Review. No abstract available.

Supplemental Content

Support Center